RESUMO
BACKGROUND: Oncology follow-up has traditionally prioritised disease surveillance and the assessment and management of symptoms associated with cancer and its treatment. Over the past decade, the focus on late effects of treatment has increased, particularly those that have an adverse effect on long-term function and quality of life. The aim of this research was to explore factors that influence the identification of treatment-induced female sexual difficulties in routine oncology follow-up after radical pelvic radiotherapy. METHODS: A structured observation schedule was used to systematically record topics discussed in 69 radiotherapy follow-up consultations observed over a 5-month period. RESULTS: Analysis suggests that physical toxicity assessment focused on bowel (81%) and bladder (70%) symptoms. Vaginal toxicity was discussed less frequently (42%) and sexual issues were explored in only 25% of consultations. Formal recording of radiation toxicity through assessment questionnaires was limited to patients participating in clinical trials. Surveillance activity and the management of active physical symptoms predominated and psychosocial issues were addressed in only 42% of consultations. INTERPRETATION: Female sexual morbidity after pelvic radiotherapy remains a neglected aspect of routine follow-up and cancer survivorship. Developments in both individual practice and service provision are necessary if the identification and management of treatment-induced female sexual difficulties is to be improved.
Assuntos
Neoplasias Colorretais/radioterapia , Neoplasias dos Genitais Femininos/radioterapia , Neoplasias Pélvicas/radioterapia , Lesões por Radiação/etiologia , Radioterapia/efeitos adversos , Disfunções Sexuais Psicogênicas/etiologia , Neoplasias Colorretais/complicações , Feminino , Seguimentos , Neoplasias dos Genitais Femininos/complicações , Humanos , Pessoa de Meia-Idade , Neoplasias Pélvicas/complicações , Qualidade de Vida , Medição de Risco , Comportamento SexualRESUMO
Men with prostate cancer have various treatment options depending upon their stage of disease, age and presence of comorbidity. However, these treatments typically induce side effects, which generate currently ill-defined supportive care needs. This study examined the supportive care needs of men with prostate cancer within England. A postal questionnaire survey was conducted in six acute NHS Trusts. Seven hundred and forty-one men with prostate cancer participated. They had been diagnosed 3-24 months prior to the survey and had received various treatments. Men surveyed had specific and significant unmet supportive care needs. Areas of greatest need are related to psychological distress, sexuality-related issues and management of enduring lower urinary tract symptoms. High levels of psychological distress were reported, and those reporting psychological distress reported greater unmet supportive care needs. Unmet sexuality-related need was highest in younger men following radical prostatectomy. Lower urinary tract symptoms were almost universal in the sample. Perceived quality of life varied; men unsure of their remission status reported lowest quality of life. Psychological distress impacts significantly on perceived unmet need and is currently not being assessed or managed well in men living with prostate cancer in England.
Assuntos
Necessidades e Demandas de Serviços de Saúde , Neoplasias da Próstata/terapia , Idoso , Inglaterra , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/fisiopatologia , Neoplasias da Próstata/psicologia , Qualidade de Vida , Medicina Estatal , Estresse Psicológico , Inquéritos e Questionários , Reino Unido , Sistema Urinário/fisiopatologiaRESUMO
This study reports results from a randomised controlled trial of nurse-led care and was designed to determine whether nurse-led follow up improved patients morbidity and satisfaction with care in men treated with radical radiotherapy for prostate and bladder cancer. The aim was to compare outcomes in terms of toxicity, symptoms experienced, quality of life, satisfaction with care and health care costs, between those receiving nurse-led care and a group receiving standard care. The study population was of men prescribed radical radiotherapy (greater than 60 Gy). Participants completed self-assessment questionnaires for symptoms and quality of life within the first week of radiotherapy treatment, at week 3, 6 and 12 weeks from start of radiotherapy. Satisfaction with clinical care was also assessed at 12 weeks post-treatment. Observer-rated RTOG toxicity scores were recorded pre-treatment, weeks 1, 3, 6 and 12 weeks from start of radiotherapy. The results presented in this paper are on 115 of 132 (87%) of eligible men who agreed to enter the randomised trial. 6 men (4%) refused and 11 (8%) were missed for inclusion in the study. Data were analysed as a comparison at cross-sectional time points and as a general linear model using multiple regression. There was no significant difference in maximum symptom scores over the time of the trial between nurse-led follow-up care and conventional medical care. Differences were seen in scores in the initial self assessment of symptoms (week 1) that may have been as a result of early nursing intervention. Those men who had received nurse-led care were significantly more satisfied (P < 0.002) at 12 weeks and valued the continuity of the service provided. There were also significant (P < 0.001) cost benefits, with a 31% reduction in costs with nurse-led, compared to medically led care. Evidence from this study suggests that a specialist nurse is able to provide safe follow up for men undergoing radiotherapy. The intervention focused on coping with symptoms, and provided continuity of care and telephone support. Further work is required to improve the management of patients during and after radiotherapy.
Assuntos
Adenocarcinoma/enfermagem , Carcinoma de Células de Transição/enfermagem , Neoplasias da Próstata/enfermagem , Radioterapia Conformacional/enfermagem , Radioterapia de Alta Energia/enfermagem , Neoplasias da Bexiga Urinária/enfermagem , Adenocarcinoma/economia , Adenocarcinoma/psicologia , Adenocarcinoma/radioterapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Carcinoma de Células de Transição/economia , Carcinoma de Células de Transição/psicologia , Carcinoma de Células de Transição/radioterapia , Análise Custo-Benefício , Custos de Medicamentos , Seguimentos , Custos Hospitalares , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação em Enfermagem , Cooperação do Paciente , Satisfação do Paciente , Neoplasias da Próstata/economia , Neoplasias da Próstata/psicologia , Neoplasias da Próstata/radioterapia , Qualidade de Vida , Lesões por Radiação/epidemiologia , Lesões por Radiação/etiologia , Lesões por Radiação/enfermagem , Lesões por Radiação/psicologia , Radioterapia Conformacional/efeitos adversos , Radioterapia Conformacional/economia , Radioterapia de Alta Energia/efeitos adversos , Radioterapia de Alta Energia/economia , Reino Unido , Neoplasias da Bexiga Urinária/economia , Neoplasias da Bexiga Urinária/psicologia , Neoplasias da Bexiga Urinária/radioterapiaRESUMO
Taking their lead from patients' needs, innovative practitioners are coming to new prescribing arrangements that are free from past constraints. One such innovation involves nurses making decisions to give a drug according to a predetermined criteria with the support of a medical practitioner. This paper shows how a carefully organised system of administering drugs against protocol can work and how it is proving beneficial to patients.